Literature DB >> 7419884

Treatment of compression neuropathy of the ulnar nerve at the elbow by epicondylectomy and neurolysis.

A I Froimson, F Zahrawi.   

Abstract

Compression neuropathy of the ulnar nerve at the elbow is treated by neurolysis and excision of the medial humeral epicondyle without transposing the ulnar nerve anteriorly. Removal of the medial humeral epicondyle is not associated with loss of motion at the elbow or reduction in strength of finger or wrist flexion because of the multiple muscle origins, as well as the firm healing of the common flexor origin to the resected bone surface. Thirty cases were treated between 1965 and 1977. Treatment halted progression of the disease in all patients. Discomfort and pain subsided in every instance. All 12 of the grade I patients had return of normal nerve function. Four of the 12 grade II patients were left with some weakness. Four of the six grade III patients improved to grade II status. None required secondary procedures on the ulnar nerve.

Entities:  

Mesh:

Year:  1980        PMID: 7419884     DOI: 10.1016/s0363-5023(80)80183-3

Source DB:  PubMed          Journal:  J Hand Surg Am        ISSN: 0363-5023            Impact factor:   2.230


  4 in total

1.  Anatomical basis for a technique of ulnar nerve transposition.

Authors:  P C Amadio
Journal:  Surg Radiol Anat       Date:  1986       Impact factor: 1.246

2.  The cubital tunnel: a radiologic and histotopographic study.

Authors:  Veronica Macchi; Cesare Tiengo; Andrea Porzionato; Carla Stecco; Gloria Sarasin; Shane Tubbs; Nicola Maffulli; Raffaele De Caro
Journal:  J Anat       Date:  2014-06-10       Impact factor: 2.610

3.  Posttraumatic ulnar neuropathy versus non-traumatic cubital tunnel syndrome: clinical features and response to surgery.

Authors:  C Barrios; C Ganoza; J de Pablos; J Cañadell
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

4.  Effects of tendon transfer to restore index finger abduction for severe cubital tunnel syndrome.

Authors:  Shingo Nobuta; Katsumi Sato; Kenji Kanazawa; Masahito Hatori; Eiji Itoi
Journal:  Ups J Med Sci       Date:  2009       Impact factor: 2.384

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.